Lavo Life Sciences specializes in AI-accelerated crystal structure prediction for small molecule drugs, helping drug development teams minimize risks, optimize formulations, and discover novel polymorphs.
• ai-powered crystal structure prediction
• reduced turnaround time
• discovery of novel polymorphs
• optimized drug formulations
• minimized risk of unexpected crystal forms
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
AI Healthtech for better and safer drug development using patient data insights.
View DetailsAI solutions for drug development, improving efficiency and outcomes in clinical trials.
View DetailsAI solutions for drug development, increasing the probability of success through data-driven insights.
View DetailsA federated AI framework that integrates decentralized data sources for AI development.
View Details